✦ LIBER ✦

Systemic inhibition of tumor growth by soluble Flk-1 gene therapy combined with cisplatin

✍ Scribed by Wang, R; Zhang, X-W; Wang, G-Q; Chen, X-C; Tian, L; Yang, H-S; Hu, M; Peng, F; Yang, J-L; He, Q-M

Book ID: 110019358
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 296 KB
Volume: 13
Category: Article
ISSN: 0929-1903
DOI: 10.1038/sj.cgt.7700958

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-tumor angiogenesis therapy using so

Anti-tumor angiogenesis therapy using soluble receptors: enhanced inhibition of tumor growth when soluble fibroblast growth factor receptor-1 is used with soluble vascular endothelial growth factor receptor

✍ Ogawa, Tadashi; Takayama, Koichi; Takakura, Nobuyuki; Kitano, Seigo; Ueno, Hikar 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 505 KB

Inhibition of ascites tumor growth in vi

Inhibition of ascites tumor growth in vivo by sTie-2 is potentiated by a combinatorial therapy with sFLT-1

✍ Saritha Sandra D'Souza; Anupama E. Gururaj; Harsha M. Raj; Jochen Rössler; Bhara 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 494 KB 👁 1 views

## Abstract ## Background Inhibition of tumor angiogenesis is a promising approach for cancer therapy and the Tie‐2/angiopoietin pathway appears to play an important role. In the present study, we have developed strategies to explore the therapeutic potential of blocking the Tie‐2/angiopoietin pat

Growth inhibition of the pulmonary metas

Growth inhibition of the pulmonary metastatic tumors by systemic delivery of the p27kip1 gene using lyophilized lipid-polycation-DNA complexes

✍ Xun Sun; Hong-Wei Zhang; Zhi-Rong Zhang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB

## Abstract ## Background p27^kip1^ (p27), a cyclin‐dependent kinase inhibitor (CDKI), is an important regulator of cell cycle progression and a putative tumor suppressor gene, and plays an important role in the inhibition of genesis and progression of several kinds of cancers. The present study a

Cancer gene therapy mediated by CTS1, a

Cancer gene therapy mediated by CTS1, a p53 derivative: Advantage over wild-type p53 in growth inhibition of human tumors overexpressing MDM2

✍ Bougeret, Cécile; Virone-Oddos, Angela; Adeline, Emmanuelle; Lacroix, Frédéric; 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 907 KB

ERK1/2 inhibition increases antiestrogen

ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERα: a combination therapy potentially targeting hypoxic and dormant tumor cells

✍ Kronblad, Åsa; Hedenfalk, Ingrid; Nilsson, Elise; Påhlman, Sven; Landberg, Göran 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 366 KB